Balchem Corporation (BCPC): Price and Financial Metrics

Balchem Corporation (BCPC): $145.28

-0.03 (-0.02%)

POWR Rating

Component Grades













Add BCPC to Watchlist
Sign Up

Industry: Chemicals


of 93

in industry


  • BCPC scores best on the Stability dimension, with a Stability rank ahead of 94.39% of US stocks.
  • BCPC's strongest trending metric is Growth; it's been moving down over the last 48 weeks.
  • BCPC ranks lowest in Value; there it ranks in the 15th percentile.

BCPC Stock Summary

  • BCPC's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 330.77 -- higher than 90.93% of US-listed equities with positive expected earnings growth.
  • Balchem Corp's stock had its IPO on June 3, 1986, making it an older stock than 92.43% of US equities in our set.
  • The volatility of Balchem Corp's share price is greater than that of only 11.27% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Balchem Corp are CXDO, SREV, HAE, XGN, and KRKR.
  • Visit BCPC's SEC page to see the company's official filings. To visit the company's web site, go to

BCPC Valuation Summary

  • BCPC's price/sales ratio is 6.1; this is 281.25% higher than that of the median Basic Materials stock.
  • BCPC's EV/EBIT ratio has moved up 23.5 over the prior 243 months.
  • Over the past 243 months, BCPC's price/sales ratio has gone up 3.5.

Below are key valuation metrics over time for BCPC.

Stock Date P/S P/B P/E EV/EBIT
BCPC 2021-09-03 6.1 5.2 50.7 38.7
BCPC 2021-09-02 6.2 5.3 51.2 39.1
BCPC 2021-09-01 6.1 5.2 50.4 38.5
BCPC 2021-08-31 6.1 5.2 50.6 38.6
BCPC 2021-08-30 6.1 5.2 50.2 38.3
BCPC 2021-08-27 6.0 5.1 49.7 37.9

BCPC Growth Metrics

  • Its year over year revenue growth rate is now at 8.13%.
  • Its 2 year price growth rate is now at -6.02%.
  • Its 4 year revenue growth rate is now at 21.8%.
BCPC's revenue has moved up $104,470,000 over the prior 33 months.

The table below shows BCPC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 743.874 159.703 89.872
2021-03-31 714.864 168.536 88.266
2020-12-31 703.644 150.494 84.623
2020-09-30 689.458 135.507 82.844
2020-06-30 672.913 142.829 81.952
2020-03-31 661.112 124.543 80.656

BCPC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BCPC has a Quality Grade of B, ranking ahead of 80.84% of graded US stocks.
  • BCPC's asset turnover comes in at 0.637 -- ranking 45th of 90 Chemicals stocks.
  • FF, ICL, and AVD are the stocks whose asset turnover ratios are most correlated with BCPC.

The table below shows BCPC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.637 0.311 0.229
2021-03-31 0.615 0.318 0.213
2020-12-31 0.607 0.318 0.196
2020-09-30 0.596 0.321 0.180
2020-06-30 0.590 0.326 0.176
2020-03-31 0.586 0.329 0.175

BCPC Price Target

For more insight on analysts targets of BCPC, see our BCPC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $150.75 Average Broker Recommendation 1.5 (Moderate Buy)

BCPC Stock Price Chart Interactive Chart >

Price chart for BCPC

BCPC Price/Volume Stats

Current price $145.28 52-week high $147.11
Prev. close $145.31 52-week low $94.97
Day low $143.94 Volume 115,900
Day high $147.11 Avg. volume 114,703
50-day MA $135.23 Dividend yield 0.4%
200-day MA $126.98 Market Cap 4.70B

Balchem Corporation (BCPC) Company Bio

Balchem Corporation consists of four business segments: ARC Specialty Products, SensoryEffects (formerly Food, Pharma and Nutrition), Animal Nutrition & Health, and Industrial Products. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The company was founded in 1967 and is based in New Hampton, New York.

BCPC Latest News Stream

Event/Time News Detail
Loading, please wait...

BCPC Latest Social Stream

Loading social stream, please wait...

View Full BCPC Social Stream

Latest BCPC News From Around the Web

Below are the latest news stories about Balchem Corp that investors may wish to consider to help them evaluate BCPC as an investment opportunity.

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

AzurRx expands Board of Directors to seven members with new appointmentBOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately. The appointment increases the size of AzurRx’s Board to seven members. Ms. Coelho currently serves

Yahoo | August 16, 2021

Balchem Corporation (BCPC) Q2 2021 Earnings Call Transcript

Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending June 30, 2021. My name is Martin Bengtsson, Chief Financial Officer; and hosting this call with me is Ted Harris, our Chairman, CEO and President.

Yahoo | July 31, 2021

Did they just beat EPS? Balchem (NASDAQ:BCPC)

Earnings results for Balchem , Analyst Opinion on Balchem , Earnings and Valuation of (NASDAQ:BCPC), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Did they just beat EPS? Balchem (NASDAQ:BCPC) appeared first on .

Stock Market Daily | July 30, 2021

Balchem Corporation Reports Record Second Quarter Sales of $202.4 Million, Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.93

NEW HAMPTON, N.Y., July 30, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today record second quarter net earnings of $22.7 million for 2021, compared to net earnings of $21.1 million for the second quarter 2020, adjusted net earnings(a) of $30.4 million, compared to $27.6 million in the prior year quarter, and adjusted EBITDA(a) of $50.1 million, compared to $43.9 million in the prior year quarter. Second Quarter 2021 Financial Highlights: Net sales were $202.4 million, a

Yahoo | July 30, 2021

Balchem Corporation to Present at the Jefferies Virtual Industrials Conference August 4, 2021

NEW HAMPTON, N.Y., July 28, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President, Ted Harris and Chief Financial Officer, Martin Bengtsson will present at the Jefferies Virtual Industrials Conference on August 4, 2021. Balchems presentation will begin at 9:00 a.m. (ET).

Intrado Digital Media | July 28, 2021

Read More 'BCPC' Stories Here

BCPC Price Returns

1-mo 8.30%
3-mo 10.23%
6-mo 15.10%
1-year 52.67%
3-year 29.59%
5-year 115.86%
YTD 26.09%
2020 13.96%
2019 30.38%
2018 -2.19%
2017 -3.46%
2016 38.66%

BCPC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BCPC Dividend History

Continue Researching BCPC

Want to see what other sources are saying about Balchem Corp's financials and stock price? Try the links below:

Balchem Corp (BCPC) Stock Price | Nasdaq
Balchem Corp (BCPC) Stock Quote, History and News - Yahoo Finance
Balchem Corp (BCPC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.141 seconds.